In myelofibrosis, combinations of rufolitinib reduce spleen volume.

Published Date: 15 Dec 2023

More patients experienced reductions when pelabresib or navitoclax were combined.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

2.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

3.

Prostate cancer detection with PET CT and PET MRI is comparable.

4.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

5.

Benzene in Cold Med; Male Cancer Death to Rise 93%; Mail-Order Drugs Compromised?


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot